medigraphic.com
ISSN 1405-8871 (Print)

2023, Number 2

<< Back Next >>

Aten Fam 2023; 30 (2)

Association Between Depressive Symptoms and Metabolic Syndrome in People Over 45 Years of Age

De Alba-Melchor JS, Chacón-Valladares P, Lajud-Ávila N

Language: Spanish
References: 32
Page: 153-159
PDF size: 160.43 Kb.


ABSTRACT

Objective: To determine the frequency of depressive symptoms and metabolic syndrome in patients over 45 years of age, as well as their possible associations. Methods: analytical cross-sectional study. 120 participants assigned to Family Medicine Unit No. 80 of the Mexican Institute of Social Security were included. Depressive symptoms were assessed using the Beck Depression Inventory-II. Participants’ anthropometric measurements were analyzed; fasting glucose concentration, triglycerides, and HDL cholesterol in blood. Pearson’s χ2 analysis was performed to test for differences in dichotomous qualitative variables and odds ratio was used to calculate risk with a 95% confidence interval. Results: the frequency of metabolic syndrome was 93.3%, of which 51.7% reported depressive symptoms. The frequency of depressive symptoms was higher in women than in men (MR= 2.1, 95% CI:1.2- 3.7, p= 0.009). Neither association was observed between depressive symptoms or metabolic syndrome, nor with its components. Conclusion: the frequency of metabolic syndrome in the studied population was higher than the previously reported and 53.3% of people with metabolic syndrome reported depressive symptoms; these were more frequent in women, and showed no association with metabolic syndrome.


REFERENCES

  1. Palacios A, Durán M, Obregón O. Factores deriesgo para el desarrollo de diabetes tipo 2 y síndromemetabólico. Rev Venez Endocrinol Metab. 2012;10(1):34-40.

  2. Lamichhane DK, Heo YS, Kim HC. DepressiveSymptoms and Risk of Absence Among Workers ina Manufacturing Company: a 12-Month Follow-Up Study. Ind Health. 2018;56(3):187-197.

  3. Macías SA, Villarreal PHJ. Sostenibilidad delgasto público: cobertura y financiamiento de enfermedadescrónicas en México. Ens Rev Econ.2018;37(1):99-133.Alba-Melchor J. y cols.Aten Fam. 2023;30(2):153-159. http://dx.doi.org/10.22201/fm.14058871p.2023.2.85033

  4. Goldbacher EM, Bromberger J, Matthews KA. Lifetimehistory of major depression predicts the developmentof the metabolic syndrome in middle-agedwomen. Psychosom Med 2009;71(3):266-72.

  5. Ortíz MS, Sapunar J. Estrés psicológico y síndromemetabólico. Rev Méd Chile. 2018;146(11):1278-1285.

  6. Bahar A, Kashi Z, Kheradmand M, Hedayatizadeh-Omran A, Moradinazar M, Ramezani F, et al. Prevalenceof metabolic syndrome using internationaldiabetes federation, National Cholesterol EducationPanel- Adult Treatment Panel III and Iranian criteria:results of Tabari cohort study. J Diabetes MetabDisord. 2020;19(1):205-211.

  7. Capapey J, Parellada E. El trastorno depresivo enAtención Primaria. Med Integr. 2002;40(6):256-266.

  8. Ansoleaga ME, Miranda-Hiriart G. Depresión ycondiciones de trabajo: revisión actualizada de la investigación.Rev Costarric Psicol. 2014;33(1):1-14.

  9. Wagner FA, González-Forteza C, Sánchez-GarcíaS, García-Peña C, Gallo JJ. Enfocando la depresióncomo problema de salud pública en México. SaludMent. 2012;35(1):3-11.

  10. Besedovsky HO, del Rey A. Immune - neuro - endocrineinteractions: facts and hypotheses. EndocrRev. 1996;17(1):64-102.

  11. Zanoveli JM, Morais Hd, Dias IC, Schreiber AK,Souza CP, Cunha JM. Depression associated withdiabetes: from pathophysiology to treatment. CurrentDiab Rev. 2016;12(3):165-178.

  12. Shoelson SE, Lee J, Goldfine AB. Inflammation andinsulin resistance. J Clin Invest. 2006;116(8):1793-1801.

  13. Whitworth JA, Williamson PM, Mangos G, KellyJJ. Cardiovascular consequences of cortisol excess.Vasc Health Risk Manag. 2005;1(4):291-299.

  14. Korten NC, Comijs HC, Lamers F, Penninx BW.Early and late onset depression in young andmiddle aged adults: differential symptomatology,characteristics and risk factors? J Affect Disord.2012;138(3):259-67.

  15. Park YW, Zhu S, Palaniappan L, Heshka S, CarnethonMR, Heymsfield SB. The metabolic syndrome:prevalence and associated risk factor findings inthe US Population from the Third National Healthand Nutrition Examination Survey, 1988-1994.Arch Intern Med. 2003;163(4):427-436.

  16. Zambrano E, Reyes-Castro LA, Nathanielsz PW.Aging, glucocorticoids and developmental programming.Age (Dordr). 2015;37(3):9774.

  17. McEwen BS. Sex, stress and the hippocampus: allostasis,allostatic load and the aging process. NeurobiolAging. 2002;23(5):921-39.

  18. López CSM, Alveano HJ, Carranza MJ. Prevalenciade síntomas depresivos en síndrome metabólico.Rev Fac Nac Salud Pública. 2008;26(2):124-133.

  19. Zimmet P, Albertib KG, Serrano RM. Una nuevadefinición mundial del síndrome metabólicopropuesta por la Federación Internacional de Diabetes:fundamento y resultados. Rev Esp Cardiol.

  20. 2005;58(12):1371-1376.20. González DA, Reséndiz RA, Reyes-Lagunes I.Adaptation of the BDI-II in Mexico. Salud Ment.2015;38(4):237-244.

  21. Wacher-Rodarte N. II. Epidemiología del síndromemetabólico. Gac Med Mex. 2009;145(5):384-391

  22. Rojas-Martínez R, Aguilar-Salinas CA, Romero-Martínez M, Castro-Porras L, Gómez-Velasco D,Mehta R. Trends in the prevalence of metabolicsyndrome and its components in Mexican adults,2006-2018. Salud Publica Mex. 2021;63:713-724

  23. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, VallesV, Ríos-Torres JM, Franco A, et al. High prevalenceof metabolic syndrome in Mexico. Arch MedRes. 2004;35(1):76-81.

  24. Gutiérrez-Solis AL, Datta Banik S, Méndez-GonzálezRM. Prevalence of Metabolic Syndrome inMexico: A Systematic Review and Meta-Analysis.Metab Syndr Relat Disord. 2018;16(8):395-405.

  25. Shamah-Levy T, Vielma-Orozco E, Heredia-HernándezO, Romero-Martínez M, Mojica-Cuevas J,Cuevas-Nasu L, et al. Encuesta Nacional de Salud yNutrición 2018 - 19: Resultados Nacionales. Cuernavaca,México: Instituto Nacional de Salud Pública,2020.

  26. Ocampo M, Santa C. Salud Mental en México. INCyTU.2018;(7):1-6.

  27. Martínez-Mendoza MC, Gutiérrez-Mendía A,Bonaparte-Caballero E, Gómez-Alonso C, LajudN. Prevalencia de Depresión en Adultos Mayores enuna Unidad de Medicina Familiar de Michoacán.Aten Fam. 2021;28(2):118-124

  28. Morales-Ramírez D, Martínez-Lara V, Reyna-Castillo,MA. Depresión, Ansiedad y Estrés en Usuariosde Atención Primaria durante el Confinamientopor Coronavirus. Rev Med Inst Mex Seguro Soc.2021;59(5):387-94.

  29. Jiang B, Zheng Y, Chen Y, Chen Y, Li Q, Zhu C, etal. Age and gender-specific distribution of metabolicsyndrome components in East China: role of hypertriglyceridemiain the SPECT-China Study. LipidsHealth Dis. 2018;17(1):92.

  30. Kuk JL, Ardern CI. Age and sex differences inthe clustering of metabolic syndrome factors:association with mortality risk. Diabetes Care.2010;33(11):2457-61.

  31. Martínez VMA, Hernández MMB, Godínez TED.Depresión en un grupo de pacientes con DiabetesMellitus Tipo 2 en una Clínica Regional del Municipiode Jilotepec, México. Aten Fam. 2012;19(3):58-60.

  32. Wen Y, Liu G, Shang Y, Wang Q. Association ofDepression with Metabolic Syndrome in HighlyEducated Ethnic Koreans of China: A Case-ControlStudy. Neuropsychiatr Dis Treat. 2021;17:57-66.




2020     |     www.medigraphic.com